Company Filing History:
8 out of 8 
4 out of 6 
2 out of 265 
Years Active: 2004-2020
Title: The Innovations of Daniel R. Richards: Pioneering Genetic Testing Technology
Introduction
Daniel R. Richards, an esteemed inventor based in Palo Alto, CA, has made significant contributions to the field of genetic testing. With a portfolio of 12 patents, his work focuses on developing methods and systems that enhance the interpretation and reporting of sequence-based genetic tests. His inventions are essential for advancing clinical research and patient care.
Latest Patents
Richards' latest patents include innovative systems and methodologies for interpreting genetic data. One notable patent is for “Methods and systems for interpretation and reporting of sequence-based genetic tests.” This invention encompasses a system, method, and computer program product designed to assist in interpreting variants found in clinical sequencing data. It effectively receives clinical trial enrollment criteria from users and searches a knowledge base for patients matching these criteria, thereby aiding in targeted clinical trials.
Another significant patent is for “Methods and systems for interpretation and reporting of sequence-based genetic tests using pooled allele statistics.” This invention involves building a community database of allele counts. It operates by receiving human variant datasets from users who consent to share their observations. The system then determines which variant observations meet specific inclusion criteria and calculates anonymized allele statistics from these pooled observations.
Career Highlights
Daniel R. Richards has spent a commendable career working with companies at the forefront of biotechnology and genetics. He has held positions at Ingenuity Systems, Inc. and Qiagen Redwood City, Inc., where he collaborated on developing cutting-edge technologies that improve genetic analysis and interpretation.
Collaborations
Throughout his career, Richards has collaborated with notable professionals in the field, including Raymond J. Cho and Richard O. Chen. Their combined expertise has contributed to the development of revolutionary genetic testing methodologies that are utilized in clinical settings today.
Conclusion
Daniel R. Richards stands out as an influential inventor in the realm of genetic testing technologies. With a focus on improving the interpretation of genetic data, his patents reflect a commitment to advancing medical science. His collaborations with leading biotech companies and professionals underscore the impact of his work on the future of genetic testing and patient care.